{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:41:55Z","timestamp":1784522515378,"version":"3.55.0"},"reference-count":22,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.<\/jats:p>","DOI":"10.1080\/08897077.2020.1752351","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T09:47:17Z","timestamp":1587462437000},"page":"147-149","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":105,"title":["Opioid Use Disorder and the Covid 19 Pandemic: A Call to Sustain Regulatory Easements and Further Expand Access to Treatment"],"prefix":"10.1177","volume":"41","author":[{"given":"Traci C.","family":"Green","sequence":"first","affiliation":[{"name":"Opioid Policy Research Collaborative, Institute for Behavioral Health at The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachussetts, USA;"},{"name":"Department of Emergency Medicine and Epidemiology, The Warren Alpert School of Medicine of Brown University, Rhode Island Hospital, Providence, Rhode Island, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-5768","authenticated-orcid":false,"given":"Jeffrey","family":"Bratberg","sequence":"additional","affiliation":[{"name":"University of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-9640","authenticated-orcid":false,"given":"Deborah S.","family":"Finnell","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Nursing, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1803982"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.3685"},{"key":"e_1_3_1_4_2","unstructured":"GovTrack. Summary of H.R. 2482: Mainstreaming Addiction Treatment Act of 2019. GovTrack.us; 2020. https:\/\/www.govtrack.us\/congress\/bills\/116\/hr2482\/summary. Accessed February 7 2020."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.07.006"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.17226\/25626"},{"key":"e_1_3_1_7_2","unstructured":"MARA International.\u2122 Medication-Assisted Recovery Anonymous; 2020. https:\/\/www.mara-international.org\/. Accessed March 26 2020."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2015.978675"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-014-9904-5"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.2012000p7"},{"key":"e_1_3_1_11_2","unstructured":"Elflein J Number of pharmacists in the U.S. from 2001 to 2016. Statista; 2018. https:\/\/www.statista.com\/statistics\/185723\/number-of-pharmacists-in-the-us-since-2001\/. Accessed March 22 2020."},{"key":"e_1_3_1_12_2","first-page":"1","article-title":"Pharmacy on-site overdose protocols and prevention of overdose","volume":"11","author":"Green TC","year":"2020","unstructured":"Green TC, , Soipe A, , Baloy B, . Pharmacy on-site overdose protocols and prevention of overdose. Sub Abuse. 2020;11:1\u20135.","journal-title":"Sub Abuse"},{"key":"e_1_3_1_13_2","unstructured":"American Pharmacists Association. Increasing access to and advocacy for medications for opioid use disorder; 2020. https:\/\/www.pharmacist.com\/sites\/default\/files\/audience\/NBI%20%2308%20-%20Medications%20for%20Opioid%20Use%20Disorder%20. (MOUD)-FINAL_0.pdf. Accessed March 26 2020."},{"key":"e_1_3_1_14_2","unstructured":"Substance Abuse and Mental Health Services Administration. FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency; 2020. https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf. Accessed March 22 2020."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2017.12.009"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4801-3"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4851"},{"key":"e_1_3_1_18_2","unstructured":"Levander XA Wakeman SE. Covid-19 will worsen the opioid overdose crisis is we don't prepare now. STAT; 2020. https:\/\/www.statnews.com\/2020\/03\/17\/covid-19-will-worsen-the-opioid-overdose-crisis-if-we-dont-prepare-now\/. Accessed March 26 2020."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1543382"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1101733"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.outlook.2017.07.001"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2019.00859"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105780"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2020.1752351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2020.1752351","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2020.1752351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:00:42Z","timestamp":1780491642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2020.1752351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1080\/08897077.2020.1752351"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2020.1752351","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}